A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61P 3/10 (2006.01) A61P 5/50 (2006.01)
Patent
CA 2331410
Methods for treating diabetes by administering an inhibitor of GDF-8, or a related member of Transforming Growth Factor-beta (TGF-.beta.) superfamily of structurally-related growth factors (e.g., GDF-11) are disclosed. Also disclosed are methods for upregulating expression of hexose transporters, such as GLUT4 and GLUT1, in a subject by administering an inhibitor of GDF-8. Also disclosed are methods for increasing glucose uptake by cells in a subject, by administering an inhibitor of GDF-8.
L'invention se rapporte à des méthodes de traitement du diabète consistant à administrer un inhibiteur de GDF-8, ou un élément associé de la superfamille du facteur de croissance transformant bêta (TGF- beta ) constituée des facteurs de croissance structurellement associés (par exemple, GDF-11). L'invention se rapporte également à des méthodes visant à effectuer, chez un sujet, une régulation positive de l'expression des transporteurs d'hexose, tels que GLUT4 et GLUT1, et consistant à administrer audit sujet un inhibiteur de GDF-8. L'invention se rapporte également à des méthodes visant à accroître l'assimilation de glucose par les cellules chez un sujet, et consistant à administrer un inhibiteur de GDF-8.
Liang Li-Fang
Strassmann Gideon
Topouzis Stavros
Borden Ladner Gervais Llp
Metamorphix Inc.
LandOfFree
Methods for treating diabetes by inhibiting gdf-8 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treating diabetes by inhibiting gdf-8, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating diabetes by inhibiting gdf-8 will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1617300